DJIA 17,678.70 6.10 0.03%
NASDAQ 4,771.76 13.88 0.29%
S&P 500 2,057.09 5.27 0.26%
market minute promo

Abbott Laboratories (NYSE: ABT)

44.15 0.29 (0.66%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ABT $44.15 0.66%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $43.74
Previous Close $43.86
Daily Range $43.42 - $44.20
52-Week Range $35.65 - $46.50
Market Cap $66.5B
P/E Ratio 34.81
Dividend (Yield) $0.96 (2.2%)
Ex-Dividend Date
Dividend Pay Date
01/13/15
02/13/15
Volume 4,376,220
Average Daily Volume 5,030,137
Current FY EPS $2.26

Sector

Healthcare

Industry

Drugs

Abbott Laboratories (ABT) Description

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. Website: http://www.abbott.com/

News & Commentary Rss Feed

This Stock Could Become the Next Johnson & Johnson

Our Motley Fool contributors think that these three companies could one day be as revered as J&J.

Notable ETF Outflow Detected - VIG, QCOM, MDT, ABT

AbbVie Provides Outlook For 2015: Let's Analyze It

Feeling Good With This Med Company

March 20th Options Now Available For Abbott Laboratories (ABT)

AZN, ABT And AMGN, 3 Drugs Stocks Pushing The Industry Lower

Can AbbVie Inc. Overcome Humira’s Looming Patent Expiration?

AbbVie's most important product, Humira, will lose patent exclusivity in the U.S. in 2016. Should investors fear this upcoming event?

10 Prime Dividend Aristocrat Dogs Average 11.6% January Upsides; 10 Others Average 8.6% Downsides

DexCom Declares Preliminary Q4 '14 Revenues, Guides '15 - Analyst Blog

Abbott Laboratories (ABT) Stock Lower Today After Jefferies Downgrade

See More ABT News...

ABT's Top Competitors

ABT $44.15 (0.66%)
Current stock: ABT
JNJ $102.26 (0.06%)
Current stock: JNJ
NVS $96.49 (-0.39%)
Current stock: NVS
RHHBY $35.48 (0.39%)
Current stock: RHHBY